Future directions for use guanidine derivatives in veterinary medicine and agricultural production (review)
Bulletin "Veterinary biotechnology" · 2017
DOI: 10.31073/vet_biotech30-18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin "Veterinary biotechnology", 2017. Verfasst von A. V. Lysytsya und 2 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
mice amounts to 5283 mg/kg.The value of LD50 at intragastric administration to rats amounts to 6100 mg/kg.This allows attributing aerosol "Metrazol-bio" to the fourth class of danger.The specified cumulation coefficient amounted to 7.4, which allows attributing medication to preparation without cumulative effect.Further studies will relate to the definition of chronic toxicity, embryotoxic and teratogenic properties of "Metrazol-bio".
Zitieren
APA
Lysytsya, A. V., Mandygra, Y. M., & Vysotsky, A. A. (2017). Future directions for use guanidine derivatives in veterinary medicine and agricultural production (review). Bulletin "Veterinary biotechnology". https://doi.org/10.31073/vet_biotech30-18
Vancouver
Lysytsya AV, Mandygra YM, Vysotsky AA. Future directions for use guanidine derivatives in veterinary medicine and agricultural production (review). Bulletin "Veterinary biotechnology". 2017. doi:10.31073/vet_biotech30-18
BibTeX
@article{Lysytsya2017,
author = {Lysytsya, A. V. and Mandygra, Y. M. and Vysotsky, A. A.},
title = {Future directions for use guanidine derivatives in veterinary medicine and agricultural production (review)},
journal = {Bulletin "Veterinary biotechnology"},
year = {2017},
doi = {10.31073/vet_biotech30-18}
}
EUVIMED